HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IFF lawsuit

This article was originally published in The Rose Sheet

Executive Summary

Fragrance supplier does not anticipate $20 mil. court decision "to have a material adverse effect" on its financial results, operating results or liquidity, IFF states after Missouri circuit court ruled against the company March 15. Court awarded $20 mil. in compensatory damages to a former employee of one of IFF's customers, who claimed he sustained respiratory damage in the workplace from the facility's use of a butter flavor supplied by IFF. Company plans to appeal the decision, stating the verdict is "not supported by the evidence or the law and should therefore be reversed." Plaintiff, however, is one of a number of employees who worked at the facility owned and operated by Gilster-Mary Lee Corporation in Jasper, Miss. that are suing IFF. Firm states the majority of plaintiffs claim to have sustained lesser respiratory injuries than the awarded plaintiff...

You may also be interested in...

AAM Slams Medicare Delays For First Generics

The AAM has cited multiple reasons for the failure of Medicare Part D to get new generics to its patients, forcing up their costs. The association has offered a list of suggestions to “ensure that first generics are covered at launch, with lower cost-sharing.”

FDA Recommends Further Limiting Use Of Laparoscopic Power Morcellation

The US FDA is updating its labeling guidance on laparoscopic power morcellation to reflect new evidence showing the treatment may pose a higher cancer risk in older women, as well as to add discussion of containment systems.

Generics Firms Deterred From Continuous Manufacturing

Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts